Overview

A New Paradigm
The majority of patients with fragility fractures do not have BMD-defined osteoporosis. Addressing this issue, the VirtuOst test goes beyond BMD by providing measurements of both BMD and bone strength. This enables patients at high risk of fracture to be identified on the basis of having either osteoporosis or fragile bone strength, the latter capturing a subset of high-risk patients with osteopenia. Learn more about moving beyond BMD.

Definitive Interpretation
Following the practice guidelines of the International Society for Clinical Densitometry, a patient identified as having either osteoporosis or fragile bone strength can be considered for pharmacologic or other treatment. Confirmation by DXA is not required. Learn more our medical report.

Convenient and Cost-Effective
The VirtuOst test can be applied as an add-on analysis to most types of clinical CT exams that contain the hip and/or spine, regardless of the indication for the original CT scan. Simply send the patient's CT scan to O.N. Diagnostics and receive back a medical report by the next day.  Learn more about how the VirtuOst test is convenient and cost-effective for patients and health care providers.

Clinical Examples
The test is well suited for patients already undergoing a CT exam and who also qualify for a reimbursable BMD test, including those who have conditions or take medications that can weaken bone. Learn more the various CT exams that may be utilized for the VirtuOst test.